Comparison of 0.5M gadoterate and 1.0M gadobutrol in peripheral MRA: A prospective, single-center, randomized, crossover, double-blind study

Journal of Magnetic Resonance Imaging

Volumn 36, Issue 5, 2012, Pages 1213-1221

  Haneder, Stefan ^a   Attenberger, Ulrike I ^a   Schoenberg, Stefan O ^a   Loewe, Christian ^b   Arnaiz, Javier ^c   Michaely, Henrik J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

gadobutrol; gadoterate; MRA; PAOD

Indexed keywords

GADOBUTROL; GADOTERATE MEGLUMINE; GADOTERIC ACID; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM 1,4,7,10-TETRAAZACYCLODODECANE-N,N',N'',N'''-TETRAACETATE; HETEROCYCLIC COMPOUND; ORGANOMETALLIC COMPOUND;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTRAST SENSITIVITY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; IMAGE QUALITY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIGNAL NOISE RATIO; AGED; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DOSE RESPONSE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

AGED; CONTRAST MEDIA; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HETEROCYCLIC COMPOUNDS; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PERIPHERAL ARTERIAL DISEASE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84867759383     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23760     Document Type: Article

References (36)

1. Kramer H, Quick HH, Tombach B, Schoenberg SO, Barkhausen J,. Whole-body MRA. Eur Radiol 2008; 18: 1925-1936.
2. Ruehm SG, Hany TF, Pfammatter T, Schneider E, Ladd M, Debatin JF,. Pelvic and lower extremity arterial imaging: diagnostic performance of three-dimensional contrast-enhanced MR angiography. AJR Am J Roentgenol 2000; 174: 1127-1135.
3. Ota H, Takase K, Igarashi K, et al. MDCT compared with digital subtraction angiography for assessment of lower extremity arterial occlusive disease: importance of reviewing cross-sectional images. AJR Am J Roentgenol 2004; 182: 201-209.
4. Met R, Bipat S, Legemate DA, Reekers JA, Koelemay MJ,. Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis. JAMA 2009; 301: 415-424.
5. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113: e463-654.
6. Collins R, Cranny G, Burch J, et al. A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease. Health Technol Assess 2007; 11: 1-184.
7. Visser K, Hunink MG,. Peripheral arterial disease: gadolinium-enhanced MR angiography versus color-guided duplex US-a meta-analysis. Radiology 2000; 216: 67-77.
8. Eiberg JP, Lundorf E, Thomsen C, Schroeder TV,. Peripheral vascular surgery and magnetic resonance arteriography-a review. Eur J Vasc Endovasc Surg 2001; 22: 396-402.
9. Hay JW, Lawler E, Yucel K, et al. Cost impact of diagnostic imaging for lower extremity peripheral vascular occlusive disease. Value Health 2009; 12: 262-266.
10. Wyttenbach R, Gianella S, Alerci M, Braghetti A, Cozzi L, Gallino A,. Prospective blinded evaluation of Gd-DOTA- versus Gd-BOPTA-enhanced peripheral MR angiography, as compared with digital subtraction angiography. Radiology 2003; 227: 261-269.
11. Kramer H, Zenge M, Schmitt P, Glaser C, Reiser MF, Herrmann KA,. Peripheral magnetic resonance angiography (MRA) with continuous table movement at 3.0 T: initial experience compared with step-by-step MRA. Invest Radiol 2008; 43: 627-634.
12. Szucs-Farkas Z, Froehlich JM, Ulrich M, et al. 1.0-M gadobutrol versus 0.5-M gadoterate for peripheral magnetic resonance angiography: a prospective randomized controlled clinical trial. J Magn Reson Imaging 2008; 27: 1399-1405.
13. Koziel K, Attenberger UI, Lederle K, Haneder S, Schoenberg SO, Michaely HJ,. Peripheral MRA with continuous table movement: Imaging speed and robustness compared to a conventional stepping table technique. Eur J Radiol 2011; 80: 537-542.
14. EMEA. Questions and answers on the review of gadolinium-containing contrast agents. EMEA/727399/2009 http://www.emea.europa.eu (accessed January 2010): European Medicines Agency 2009.
15. Zenge MO, Vogt FM, Brauck K, et al. High-resolution continuously acquired peripheral MR angiography featuring partial parallel imaging GRAPPA. Magn Reson Med 2006; 56: 859-865.
16. Voth M, Haneder S, Huck K, Gutfleisch A, Schonberg SO, Michaely HJ,. Peripheral magnetic resonance angiography with continuous table movement in combination with high spatial and temporal resolution time-resolved MRA With a total single dose (0.1 mmol/kg) of gadobutrol at 3.0 T. Invest Radiol 2009; 44: 627-633.
17. Reeder SB, Wintersperger BJ, Dietrich O, et al. Practical approaches to the evaluation of signal-to-noise ratio performance with parallel imaging: application with cardiac imaging and a 32-channel cardiac coil. Magn Reson Med 2005; 54: 748-754.
18. Goyen M, Lauenstein TC, Herborn CU, Debatin JF, Bosk S, Ruehm SG,. 0.5 M Gd chelate (Magnevist) versus 1.0 M Gd chelate (Gadovist): dose-independent effect on image quality of pelvic three-dimensional MR-angiography. J Magn Reson Imaging 2001; 14: 602-607.
19. Schaefer FK, Schaefer PJ, Altjohann C, et al. A multicenter, site-independent, blinded study to compare the diagnostic accuracy of contrast-enhanced magnetic resonance angiography using 1.0M gadobutrol (Gadovist) to intraarterial digital subtraction angiography in body arteries. Eur J Radiol 2007; 61: 315-323.
20. Herborn CU, Lauenstein TC, Ruehm SG, Bosk S, Debatin JF, Goyen M,. Intraindividual comparison of gadopentetate dimeglumine, gadobenate dimeglumine, and gadobutrol for pelvic 3D magnetic resonance angiography. Invest Radiol 2003; 38: 27-33.
21. Goyen M, Herborn CU, Vogt FM, et al. Using a 1 M Gd-chelate (gadobutrol) for total-body three-dimensional MR angiography: preliminary experience. J Magn Reson Imaging 2003; 17: 565-571.
22. Tombach B, Benner T, Reimer P, et al. Do highly concentrated gadolinium chelates improve MR brain perfusion imaging? Intraindividually controlled randomized crossover concentration comparison study of 0.5 versus 1.0 mol/L gadobutrol. Radiology 2003; 226: 880-888.
23. Thilmann O, Larsson EM, Bjorkman-Burtscher IM, Stahlberg F, Wirestam R,. Comparison of contrast agents with high molarity and with weak protein binding in cerebral perfusion imaging at 3 T. J Magn Reson Imaging 2005; 22: 597-604.
24. Anzalone N, Gerevini S, Scotti R, Vezzulli P, Picozzi P,. Detection of cerebral metastases on magnetic resonance imaging: intraindividual comparison of gadobutrol with gadopentetate dimeglumine. Acta Radiol 2009; 50: 933-940.
25. Hadizadeh DR, Von Falkenhausen M, Kukuk GM, et al. Contrast material for abdominal dynamic contrast-enhanced 3D MR angiography with parallel imaging: intraindividual equimolar comparison of a macrocyclic 1.0 M gadolinium chelate and a linear ionic 0.5 M gadolinium chelate. AJR Am J Roentgenol 2010; 194: 821-829.
26. Fink C, Bock M, Kiessling F, et al. Time-resolved contrast-enhanced three-dimensional pulmonary MR-angiography: 1.0M gadobutrol vs. 0.5M gadopentetate dimeglumine. J Magn Reson Imaging 2004; 19: 202-208.
27. Heiland S, Erb G, Ziegler S, Krix M,. Where contrast agent concentration really matters - a comparison of CT and MRI. Invest Radiol 2010; 45: 529-537.
28. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ,. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005; 40: 715-724.
29. Michaely HJ, Kramer H, Dietrich O, et al. Intraindividual comparison of high-spatial-resolution abdominal MR angiography at 1.5 T and 3.0 T: initial experience. Radiology 2007; 244: 907-913.
30. Attenberger UI, Haneder S, Morelli JN, Diehl SJ, Schoenberg SO, Michaely HJ,. Peripheral arterial occlusive disease: evaluation of a high spatial and temporal resolution 3-T MR protocol with a low total dose of gadolinium versus conventional angiography. Radiology 2010; 257: 879-887.
31. Frenzel T, Lengsfeld P, Schirmer H, Hutter J, Weinmann HJ,. Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C. Invest Radiol 2008; 43: 817-828.
32. Miyazaki M, Takai H, Sugiura S, Wada H, Kuwahara R, Urata J,. Peripheral MR angiography: separation of arteries from veins with flow-spoiled gradient pulses in electrocardiography-triggered three-dimensional half-Fourier fast spin-echo imaging. Radiology 2003; 227: 890-896.
33. Miyazaki M, Lee VS,. Nonenhanced MR angiography. Radiology 2008; 248: 20-43.
34. Haneder S, Attenberger UI, Riffel P, Henzler T, Schoenberg SO, Michaely HJ,. Magnetic resonance angiography (MRA) of the calf station at 3.0 T: intraindividual comparison of non-enhanced ECG-gated flow-dependent MRA, continuous table movement MRA and time-resolved MRA. Eur Radiol 2011; 21: 1452-1461.
35. Lim RP, Hecht EM, Xu J, et al. 3D nongadolinium-enhanced ECG-gated MRA of the distal lower extremities: preliminary clinical experience. J Magn Reson Imaging 2008; 28: 181-189.
36. Hodnett PA, Koktzoglou I, Davarpanah AH, et al. Evaluation of peripheral arterial disease with nonenhanced quiescent-interval single-shot MR angiography. Radiology 2011; 260: 282-293.